Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2026)
Eton Pharmaceuticals (ETON) posted EBIT Margin of 11.58% for Q4 2025, up 290.78% sequentially from 6.07% in Q3 2025, and up 618.0% YoY from 1.61% in Q4 2024.
Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported EBIT Margin for 7 years, with the latest figure at 11.58% in Q4 2025.
- Quarterly EBIT Margin rose 618.0% year-over-year to 11.58% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.06% (up 560.0% YoY) and the FY2025 annual result came in at 1.06%, up 560.0% from the prior year.
- EBIT Margin rose to 11.58% in Q4 2025 per ETON's latest filing, from 6.07% in the prior quarter.
- Over five years, EBIT Margin peaked at 45.08% in Q1 2021 and troughed at 754.45% in Q3 2021.
- A 5-year average of 56.83% and a median of 7.24% in 2023 frame the typical range for EBIT Margin.
- The widest YoY moves for EBIT Margin: up 2261419 bps in 2021, down 24731177 bps in 2021.
- Over 5 years, EBIT Margin stood at 21.57% in 2021, then tumbled by 42 bps to 12.5% in 2022, then slumped by 154 bps to 6.69% in 2023, then soared by 181 bps to 5.4% in 2024, then surged by 114 bps to 11.58% in 2025.
- According to Business Quant data, EBIT Margin over the past three periods registered 11.58%, 6.07%, and 7.79% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 34.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.04% |
| Dec 31, 2025 | 11.58% |
| Sep 30, 2025 | -6.07% |
| Jun 30, 2025 | -7.79% |
| Mar 31, 2025 | -2.72% |
| Dec 31, 2024 | 5.40% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -10.04% |
| Dec 31, 2023 | -6.69% |
| Sep 30, 2023 | -7.80% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | -47.78% |
| Dec 31, 2022 | 12.50% |
| Sep 30, 2022 | -57.90% |
| Jun 30, 2022 | -26.80% |
| Mar 31, 2022 | -233.78% |
| Dec 31, 2021 | 21.57% |
| Sep 30, 2021 | -754.45% |
| Jun 30, 2021 | -75.81% |